Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
Open | $12.01 |
Close | $12.00 |
Volume / Avg. | 512.41K / 513.61K |
Day Range | $11.81 - $12.32 |
52 Wk Range | 10.29 - 19.62 |
Market Cap | $794.07M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 12.32% |
Days to Cover | 26.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pliant Therapeutics (NASDAQ:PLRX) through any online brokerage.
Other companies in Pliant Therapeutics’s space includes: Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and WAVE Life Sciences (NASDAQ:WVE).
Pliant Therapeutics has a consensus price target of $40.62.
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $13.06 last updated September 13, 2024 at 6:38 PM EDT.
There are no upcoming dividends for Pliant Therapeutics.
Pliant Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Pliant Therapeutics.
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.